½ÃÀ庸°í¼­
»óǰÄÚµå
1789517

°æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀå : Á¦Ç° À¯Çüº°, ¹è¼Û ½Ã½ºÅÛº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Transcatheter Heart Valve Market, By Product Type, By Delivery Systems, By End User, and By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀåÀº 2025³â¿¡´Â 59¾ï 3,000¸¸ ´Þ·¯, 2032³â¿¡´Â 147¾ï 5,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025³âºÎÅÍ 2032³â±îÁöÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 13.9%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 59¾ï 3,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â¤¤ ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø±â°£ 2025-2032³â CAGR : 13.90% 2032³â °¡Ä¡ ¿¹Ãø 147¾ï 5,000¸¸ ´Þ·¯

°æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· À̽ÄÀº ½ÉÀå ÆÇ¸·Áõ(VHD) Ä¡·á¸¦ À§ÇØ »ýü Àΰø ÆÇ¸·À¸·Î ¼Õ»óµÈ ½ÉÀå ÆÇ¸·À» º¹±¸ÇÏ´Â Àú ħ½À ½ÉÀå ¼ö¼úÀÔ´Ï´Ù. ÀüÅëÀûÀÎ °³½É¼úÀ» ´ëüÇÏ´Â Á¢±Ù¹ýÀÌ¸ç Æ¯È÷ À§ÇèÀÌ ¸Å¿ì ³ôÀº ȯÀÚ¿¡°Ô ±ÇÀåµË´Ï´Ù. ´ëµ¿¸ÆÆÇÀº ¿ÞÂÊ ÇÏ´Ü ½É½Ç(Á½ɽÇ)°ú ½ÅüÀÇ ÁÖµ¿¸Æ(´ëµ¿¸Æ) »çÀÌ¿¡ ÀÖ½À´Ï´Ù. ¹ëºê°¡ Á¦´ë·Î ¿­¸®Áö ¾ÊÀ¸¸é ½ÉÀå¿¡¼­ ¸öÀ¸·ÎÀÇ Ç÷·ù°¡ °¨¼ÒÇÕ´Ï´Ù. °æÄ«Å×ÅÍ ´ëµ¿¸Æ ÆÇ¸· ġȯ¼ú(TAVR)Àº ÁõÈļº ´ëµ¿¸Æ ÆÇ¸· ÇùÂøÁõÀ» ¾Î°í ÀÖÀ¸¸ç, Ç¥ÁØ ÆÇ¸· ġȯ¼úÀÇ À§ÇèÀÌ ³ôÀº »ç¶÷ÀÇ Ä¡·á¸¦ À§ÇØ ¹Ì±¹ FDA¿¡ ÀÇÇØ ½ÂÀεǾú½À´Ï´Ù. TAVRÀº Ç÷·ù¸¦ ȸº¹½Ã۰í ÈäÅë, È£Èí °ï¶õ, ½Ç½Å, ÇÇ·Î¿Í °°Àº ´ëµ¿¸Æ ÆÇ¸· ÇùÂøÁõÀÇ Â¡ÈÄ¿Í Áõ»óÀ» ¿ÏÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. TAVRÀº ¼ö¼ú ´ëµ¿¸Æ ÆÇ¸· ġȯ¼ú(°³½É¼ú)À¸·Î ÀÎÇÑ ÇÕº´ÁõÀÇ À§ÇèÀÌÀÖ´Â »ç¶÷ÀÇ ¼±ÅÃÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ¼¼°è ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϱâ À§ÇØ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷¿¡ ÀÇÇÑ Àμö¿Í °°Àº ¹«±âÀû ¼ºÀå Àü·«ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 6¿ù ÀÇ·á±â±â Á¦Á¶¾÷üÀÎ SMT´Â ±¸Á¶Àû ½ÉÀå ÀÇ·á±â±âÀÎ Vascular Concepts¸¦ ÀμöÇÏ¿© ½ÃÀå¿¡ ÁøÀÔÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°è °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£ 2025³â-2032³â ½ÃÀå ±Ô¸ð¿Í ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ ÁÖ¿ä °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ¿£ÅÍÇÁ¶óÀÌÁî ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°èÀÇ °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂûÀº ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀÌ ¹Ì·¡ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù.
  • °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë ¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µîÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ ´ë»óÀ¸·ÎÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°è °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • Á¦Ç° ¹ß¸Å
  • ±â¼úÀÇ Áøº¸
  • PEST ºÐ¼®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÇÕº´°ú Àμö

Á¦4Àå ¼¼°èÀÇ °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀå, Á¦Ç° ¹× ¼­ºñ½ºº°, 2020³â-2032³â

  • TAVR
  • TMVR

Á¦5Àå ¼¼°èÀÇ °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀå, ¹è¼Û ½Ã½ºÅÛº°, 2020³â-2032³â

  • Transfemoral Approach
  • Transapical Approach
  • Transaortic Approach

Á¦6Àå ¼¼°èÀÇ °æÄ«Å×ÅÍ ½ÉÀåÆÇ¸· ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°, 2020³â-2032³â

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ½ÉÀå Ä«Å×ÅÍ °Ë»ç½Ç
  • ±âŸ(Àü¹®¼¾ÅÍ µî)

Á¦7Àå ¼¼°èÀÇ °æ Ä«Å×ÅÍ ½ÉÀ庯 ½ÃÀå, Áö¿ªº°, 2020³â-2032³â

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
      • ¿µ±¹
      • µ¶ÀÏ
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ½ºÆäÀÎ
      • ·¯½Ã¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • ASEAN
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
      • GCC
      • À̽º¶ó¿¤
      • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó ¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • Edwards Lifesciences Corporation
  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • JenaValve Technology
  • SYMETIS
  • Braile Biomedica
  • CryoLife, Inc.
  • Shockwave Medical Inc.
  • Venus Medtech(Hangzhou) Inc.

Á¦9Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
SHW

Transcatheter Heart Valve Market is estimated to be valued at USD 5.93 Bn in 2025 and is expected to reach USD 14.75 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5.93 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.90% 2032 Value Projection: USD 14.75 Bn

Transcatheter heart valve implantation is a minimally-invasive heart procedure to repair damaged heart valves with bio-prosthetic valves for treatment of valvular heart disease (VHD). It is an alternative approach to conventional open heart surgery and is especially recommended for extremely high risk patients. The aortic valve is located between the left lower heart chamber (left ventricle) and the body's main artery (aorta). If the valve does not open correctly, blood flow from the heart to the body is reduced. Transcatheter aortic valve replacement (TAVR) is approved by the U.S. FDA for treating individuals suffering from symptomatic aortic stenosis and are at high risk for standard valve replacement surgery. TAVR can help restore blood flow and reduce the signs and symptoms of aortic valve stenosis - such as chest pain, shortness of breath, fainting and fatigue. TAVR may be an option for people who are at risk of complications from surgical aortic valve replacement (open-heart surgery). Increasing demand for minimally-invasive procedures is expected to boost growth of the global transcatheter heart valve market over the forecast period.

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2020, SMT, a manufacturer of medical equipment, announced that it has acquired structural heart medical device firm Vascular Concepts, to enter into the market.

Key features of the study

  • This report provides in-depth analysis of the global transcatheter heart valve market, and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global transcatheter heart valve market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study are Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation, Abbott, JenaValve Technology, SYMETIS, Braile Biomedica, CryoLife, Inc., Shockwave Medical Inc., Venus Medtech (Hangzhou) Inc.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global transcatheter heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transcatheter heart valve market.

Market Segmentation

  • Global Transcatheter Heart Valve Market, By Product Type
    • TAVR
    • TMVR
  • Global Transcatheter Heart Valve Market, By Delivery Systems
    • Transfemoral Approach
    • Transapical Approach
    • Transaortic Approach
  • Global Transcatheter Heart Valve Market, By End User
    • Hospitals
    • Ambulatory Surgical Centers
    • Cardiac Catheterization Laboratory
    • Other (Specialty Center, etc.)
  • Global Transcatheter Heart Valve Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
    • Edwards Lifesciences Corporation
    • Medtronic
    • Boston Scientific Corporation
    • Abbott, JenaValve Technology
    • SYMETIS
    • Braile Biomedica
    • CryoLife, Inc.
    • Shockwave Medical Inc.
    • Venus Medtech (Hangzhou) Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product and Services
    • Market Snapshot, By Delivery Systems
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product Launch
  • Technological Advancements
  • PEST Analysis
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Transcatheter Heart Valve Market, By Product and Services, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • TAVR
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • TMVR
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Transcatheter Heart Valve Market, By Delivery Systems, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Transfemoral Approach
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Transapical Approach
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Transaortic Approach
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Transcatheter Heart Valve Market, By End User, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segments Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Center
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiac Catheterization Laboratory
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Specialty Center, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Transcatheter Heart Valve Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Edwards Lifesciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • JenaValve Technology
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • SYMETIS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Braile Biomedica
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CryoLife, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Shockwave Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Venus Medtech (Hangzhou) Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦